Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2023

19.08.2022 | Glaucoma

Foreign body reaction after CyPass® Micro-Stent implantation: a case series

verfasst von: Kirsten J. Habbe, Markus Kohlhaas, Claus Langwieder, Sofia Fili

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively assess the histopathological particularities of explanted CyPass® Micro-Stent of patients with significant loss of endothelial cell density.

Methods

This is a case series of fourteen eyes from eleven patients who underwent CyPass® Micro-Stent implantation due to mild to moderate glaucoma and who subsequently suffered from loss of endothelial cell density. Therefore, the explantation of the device was necessary. In addition to the retrospective evaluation of the intraocular pressure and the endothelial cell density at the time of implantation and explantation, every surgically removed implant was histologically examined and evaluated.

Results

Fourteen eyes of eleven patients were in total analysed. The patients—seven males and four females—had a mean age of 62.9 years. The average time between CyPass implantation and explantation was 3.7 years. Eight patients suffered from primary-open-angle glaucoma (POAG), while two patients had a pseudoexfoliation glaucoma (PXG) and one patient had low-pressure glaucoma. Ten of the patients were already pseudophakic before the CyPass implantation and four patients underwent previously glaucoma interventions. There was a significant reduction in the intraocular pressure from 18.57 ± 5.27 mmHg at the time of implantation to 14.78 ± 3.32 mmHg at the time of explantation (p = 0.037). The average endothelial cell density decreased from 1843.67 ± 421.81 to 932.92 ± 412.86/mm2 at the time of explantation (p < 0.01). The histological findings showed a fibrous obliteration of the CyPass accompanied by a chronic granulomatous inflammation with giant cell macrophages. Histologically, these findings were consistent with a foreign body granuloma.

Conclusions

Implants made of polyimides such as the CyPass® Micro-Stent are considered to be biocompatible, but there is no guarantee not to be obliterated or encapsulated. This is the first case series that has detected a foreign body granuloma in multiple eyes after CyPass implantation. However, there is no connection with the type of glaucoma, the extent of previous operations or with the presence of a prolonged postoperative inflammatory reaction.
Literatur
1.
Zurück zum Zitat Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100CrossRef Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100CrossRef
2.
Zurück zum Zitat Anonymous (2019) Abstractband DOG 2019. Ophthalmologe 116:48 Anonymous (2019) Abstractband DOG 2019. Ophthalmologe 116:48
3.
Zurück zum Zitat Ansari E (2017) An update on implants for minimally invasive glaucoma surgery (MIGS). Ophthalmol Therapy 6:233–241CrossRef Ansari E (2017) An update on implants for minimally invasive glaucoma surgery (MIGS). Ophthalmol Therapy 6:233–241CrossRef
4.
Zurück zum Zitat Asai J (2017) What is new in the histogenesis of granulomatous skin diseases? J Dermatol 44:297–303CrossRef Asai J (2017) What is new in the histogenesis of granulomatous skin diseases? J Dermatol 44:297–303CrossRef
5.
Zurück zum Zitat Ayyala RS, Layden WE, Slonim CB et al (2001) Anatomic and histopathologic findings following a failed ahmed glaucoma valve device. Ophthalmic Surg Lasers 32:248–249CrossRef Ayyala RS, Layden WE, Slonim CB et al (2001) Anatomic and histopathologic findings following a failed ahmed glaucoma valve device. Ophthalmic Surg Lasers 32:248–249CrossRef
6.
Zurück zum Zitat Cseke I, Vámosi P, Bausz M (2016) Starflo glaucoma implant: early experience in Hungary. Romanian J Ophthalmol 60:14–17 Cseke I, Vámosi P, Bausz M (2016) Starflo glaucoma implant: early experience in Hungary. Romanian J Ophthalmol 60:14–17
7.
Zurück zum Zitat Dammak A, Taillé C, Marinho E et al (2012) Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report. Br J Dermatol 166:1375–1376CrossRef Dammak A, Taillé C, Marinho E et al (2012) Granulomatous foreign-body reaction with facial dermal fillers after omalizumab treatment for severe persistent allergic asthma: a case report. Br J Dermatol 166:1375–1376CrossRef
8.
Zurück zum Zitat De La Oliva N, Navarro X, Del Valle J (2018) Time course study of long-term biocompatibility and foreign body reaction to intraneural polyimide-based implants. J Biomed Mater Res, Part A 106:746–757CrossRef De La Oliva N, Navarro X, Del Valle J (2018) Time course study of long-term biocompatibility and foreign body reaction to intraneural polyimide-based implants. J Biomed Mater Res, Part A 106:746–757CrossRef
9.
Zurück zum Zitat Denis P, Hirneiß C, Reddy KP et al (2019) A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I). Ophthalmol Glaucoma 2:290–297CrossRef Denis P, Hirneiß C, Reddy KP et al (2019) A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I). Ophthalmol Glaucoma 2:290–297CrossRef
10.
Zurück zum Zitat Dorhoi A, Reece ST, Kaufmann SH (2011) For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol Rev 240:235–251CrossRef Dorhoi A, Reece ST, Kaufmann SH (2011) For better or for worse: the immune response against Mycobacterium tuberculosis balances pathology and protection. Immunol Rev 240:235–251CrossRef
11.
Zurück zum Zitat Fili S, Seddig S, Papadopoulou E et al (2019) One-year results after CyPass implantation. Ophthalmologe 116:447–455CrossRef Fili S, Seddig S, Papadopoulou E et al (2019) One-year results after CyPass implantation. Ophthalmologe 116:447–455CrossRef
12.
Zurück zum Zitat Fili S, Seddig S, Vastardis I et al (2021) Explantation of the CyPass implant in a case series of patients with corneal decompensation. Ophthalmologe 118:42–49CrossRef Fili S, Seddig S, Vastardis I et al (2021) Explantation of the CyPass implant in a case series of patients with corneal decompensation. Ophthalmologe 118:42–49CrossRef
13.
Zurück zum Zitat Fili S, Wölfelschneider P, Kohlhaas M (2018) The STARflo glaucoma implant: preliminary 12 months results. Graefes Arch Clin Exp Ophthalmol 256:773–781CrossRef Fili S, Wölfelschneider P, Kohlhaas M (2018) The STARflo glaucoma implant: preliminary 12 months results. Graefes Arch Clin Exp Ophthalmol 256:773–781CrossRef
14.
Zurück zum Zitat García-Feijoo J, Rau M, Grisanti S et al (2015) Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol 159:1075-1081.e1071CrossRef García-Feijoo J, Rau M, Grisanti S et al (2015) Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol 159:1075-1081.e1071CrossRef
15.
Zurück zum Zitat Gillmann K, Mansouri K, Bravetti GE et al (2018) Chronic intraocular inflammation as a risk factor for XEN gel stent occlusion: a case of microscopic examination of a fibrin-obstructed XEN stent. J Glaucoma 27:739–741CrossRef Gillmann K, Mansouri K, Bravetti GE et al (2018) Chronic intraocular inflammation as a risk factor for XEN gel stent occlusion: a case of microscopic examination of a fibrin-obstructed XEN stent. J Glaucoma 27:739–741CrossRef
16.
Zurück zum Zitat Green W, Lind JT, Sheybani A (2018) Review of the XEN gel stent and InnFocus MicroShunt. Curr Opin Ophthalmol 29:162–170CrossRef Green W, Lind JT, Sheybani A (2018) Review of the XEN gel stent and InnFocus MicroShunt. Curr Opin Ophthalmol 29:162–170CrossRef
17.
Zurück zum Zitat Grierson I, Minckler D, Rippy M (2018) Pre-clinical experience of STAR material. In: European Society of Cataract and Refractive Surgery Annual Meeting. Grierson I, Minckler D, Rippy M (2018) Pre-clinical experience of STAR material. In: European Society of Cataract and Refractive Surgery Annual Meeting.
18.
Zurück zum Zitat Grisanti S, Margolina E, Hoeh H et al (2014) Supraciliary microstent for open-angle glaucoma: clinical results of a prospective multicenter study. Ophthalmologe 111:548–552CrossRef Grisanti S, Margolina E, Hoeh H et al (2014) Supraciliary microstent for open-angle glaucoma: clinical results of a prospective multicenter study. Ophthalmologe 111:548–552CrossRef
19.
Zurück zum Zitat Hoeh H, Vold SD, Ahmed IK et al (2016) Initial clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary microstent. J Glaucoma 25:106–112CrossRef Hoeh H, Vold SD, Ahmed IK et al (2016) Initial clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary microstent. J Glaucoma 25:106–112CrossRef
20.
Zurück zum Zitat Höh H, Grisanti S, Grisanti S et al (2014) Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd 231:377–381CrossRef Höh H, Grisanti S, Grisanti S et al (2014) Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd 231:377–381CrossRef
22.
Zurück zum Zitat Jacob JT, Burgoyne CF, Mckinnon SJ et al (1998) Biocompatibility response to modified Baerveldt glaucoma drains. J Biomed Mater Res 43:99–107CrossRef Jacob JT, Burgoyne CF, Mckinnon SJ et al (1998) Biocompatibility response to modified Baerveldt glaucoma drains. J Biomed Mater Res 43:99–107CrossRef
23.
Zurück zum Zitat Janas A, Milewski K, Buszman PP et al (2015) Safety and biocompatibility of a novel self-expanding nitinol carotid stent with hybrid cell design in a porcine model of neointimal hyperplasia. Kardiol Pol 73:240–245CrossRef Janas A, Milewski K, Buszman PP et al (2015) Safety and biocompatibility of a novel self-expanding nitinol carotid stent with hybrid cell design in a porcine model of neointimal hyperplasia. Kardiol Pol 73:240–245CrossRef
24.
Zurück zum Zitat Jung KI, Lee SB, Kim JH et al (2013) Foreign body reaction in glaucoma drainage implant surgery. Invest Ophthalmol Vis Sci 54:3957–3964CrossRef Jung KI, Lee SB, Kim JH et al (2013) Foreign body reaction in glaucoma drainage implant surgery. Invest Ophthalmol Vis Sci 54:3957–3964CrossRef
25.
Zurück zum Zitat Jung KI, Lim SA, Park HY et al (2013) Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. Ophthalmology 120:978–983CrossRef Jung KI, Lim SA, Park HY et al (2013) Visualization of blebs using anterior-segment optical coherence tomography after glaucoma drainage implant surgery. Ophthalmology 120:978–983CrossRef
26.
Zurück zum Zitat Kee HJ, Lee EJ, Han JC et al (2021) Ahmed implant coated with poly(2-methacryloyloxyethyl phosphorylcholine) inhibits foreign body reactions in rabbit eyes. PLoS ONE 16:e0252467CrossRef Kee HJ, Lee EJ, Han JC et al (2021) Ahmed implant coated with poly(2-methacryloyloxyethyl phosphorylcholine) inhibits foreign body reactions in rabbit eyes. PLoS ONE 16:e0252467CrossRef
27.
Zurück zum Zitat Lass JH, Benetz BA, He J et al (2019) Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol 208:211–218CrossRef Lass JH, Benetz BA, He J et al (2019) Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol 208:211–218CrossRef
28.
Zurück zum Zitat Olson JL, Velez-Montoya R, Erlanger M (2012) Ocular biocompatibility of nitinol intraocular clips. Invest Ophthalmol Vis Sci 53:354–360CrossRef Olson JL, Velez-Montoya R, Erlanger M (2012) Ocular biocompatibility of nitinol intraocular clips. Invest Ophthalmol Vis Sci 53:354–360CrossRef
29.
Zurück zum Zitat Reiss G, Clifford B, Vold S et al (2019) Safety and effectiveness of CyPass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study. Am J Ophthalmol 208:219–225CrossRef Reiss G, Clifford B, Vold S et al (2019) Safety and effectiveness of CyPass supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study. Am J Ophthalmol 208:219–225CrossRef
30.
Zurück zum Zitat Resende AF, Patel NS, Waisbourd M et al (2016) iStent® trabecular microbypass stent: an update. J Ophthalmol 2016:2731856 Resende AF, Patel NS, Waisbourd M et al (2016) iStent® trabecular microbypass stent: an update. J Ophthalmol 2016:2731856
31.
Zurück zum Zitat Saheb H, Ahmed Ii (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96–104CrossRef Saheb H, Ahmed Ii (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96–104CrossRef
32.
Zurück zum Zitat Salimi A, Lapointe J, Harasymowycz P (2019) One-year outcomes of second-generation trabecular micro-bypass stents (iStent Inject) implantation with cataract surgery in different glaucoma subtypes and severities. Ophthalmol Therapy 8:563–575CrossRef Salimi A, Lapointe J, Harasymowycz P (2019) One-year outcomes of second-generation trabecular micro-bypass stents (iStent Inject) implantation with cataract surgery in different glaucoma subtypes and severities. Ophthalmol Therapy 8:563–575CrossRef
33.
Zurück zum Zitat Schoelles KJ, Anton A, Auw-Haedrich C (2020) Chronic granulomatous inflammation after CyPass® implantation. Ocular Oncol Pathol 6:259–264CrossRef Schoelles KJ, Anton A, Auw-Haedrich C (2020) Chronic granulomatous inflammation after CyPass® implantation. Ocular Oncol Pathol 6:259–264CrossRef
34.
Zurück zum Zitat Sirova M, Van Vlierberghe S, Matyasova V et al (2014) Immunocompatibility evaluation of hydrogel-coated polyimide implants for applications in regenerative medicine. J Biomed Mater Res A 102:1982–1990CrossRef Sirova M, Van Vlierberghe S, Matyasova V et al (2014) Immunocompatibility evaluation of hydrogel-coated polyimide implants for applications in regenerative medicine. J Biomed Mater Res A 102:1982–1990CrossRef
35.
Zurück zum Zitat Trindade R, Albrektsson T, Galli S et al (2018) Osseointegration and foreign body reaction: titanium implants activate the immune system and suppress bone resorption during the first 4 weeks after implantation. Clin Implant Dent Relat Res 20:82–91CrossRef Trindade R, Albrektsson T, Galli S et al (2018) Osseointegration and foreign body reaction: titanium implants activate the immune system and suppress bone resorption during the first 4 weeks after implantation. Clin Implant Dent Relat Res 20:82–91CrossRef
36.
Zurück zum Zitat Tripathi RC, Borisuth NSC, Tripathi BJ (1991) Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye. Drug Dev Res 22:1–23CrossRef Tripathi RC, Borisuth NSC, Tripathi BJ (1991) Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye. Drug Dev Res 22:1–23CrossRef
37.
Zurück zum Zitat Vinod K, Gedde SJ (2021) Safety profile of minimally invasive glaucoma surgery. Curr Opin Ophthalmol 32:160–168CrossRef Vinod K, Gedde SJ (2021) Safety profile of minimally invasive glaucoma surgery. Curr Opin Ophthalmol 32:160–168CrossRef
38.
Zurück zum Zitat Vold S, Ahmed Ii, Craven ER et al (2016) Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 123:2103–2112CrossRef Vold S, Ahmed Ii, Craven ER et al (2016) Two-year COMPASS trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 123:2103–2112CrossRef
39.
Zurück zum Zitat Von Stebut E (2017) What is a granuloma? Hautarzt 68:520–525 Von Stebut E (2017) What is a granuloma? Hautarzt 68:520–525
Metadaten
Titel
Foreign body reaction after CyPass® Micro-Stent implantation: a case series
verfasst von
Kirsten J. Habbe
Markus Kohlhaas
Claus Langwieder
Sofia Fili
Publikationsdatum
19.08.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2023
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-022-05767-7

Weitere Artikel der Ausgabe 2/2023

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2023 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.